Contract research organizations (CROs) have transformed the way research are conducted by several pharmaceutical, biotechnology, and medical devices companies in ways more than one. These organizations offer a variety of services such as biopharmaceutical development, clinical trials conduct and other endeavors, drug discovery activities, product commercialization, assay development, and pharmacovigilance. The intensifying demand for new therapies and devices has mounted pressures on research and development (R&D) budgets of these organizations.?
This report contains market size and forecasts of Healthcare CRO in Global, including the following market information:
- Global Healthcare CRO Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Healthcare CRO market was valued at 43250 million in 2021 and is projected to reach US$ 62680 million by 2028, at a CAGR of 5.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Early Phase Development Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Healthcare CRO include Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, Pharmaceutical Product Development, PAREXEL International, ICON plc, PRA Health Sciences, InVentiv Health, Charles River Laboratories and INC Research Holdings and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Healthcare CRO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Healthcare CRO Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Healthcare CRO Market Segment Percentages, by Type, 2021 (%)
- Early Phase Development
- Clinical Research
- Laboratory
- Consulting Services
Global Healthcare CRO Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Healthcare CRO Market Segment Percentages, by Application, 2021 (%)
- Biopharmaceutical Companies
- Academic and Research Institutes
- Others
Global Healthcare CRO Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Healthcare CRO Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Healthcare CRO revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Healthcare CRO revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Quintiles Transnational Holdings
- Laboratory Corporation Of America Holdings
- Pharmaceutical Product Development
- PAREXEL International
- ICON plc
- PRA Health Sciences
- InVentiv Health
- Charles River Laboratories
- INC Research Holdings
- Wuxi PharmaTech
